FDA Clears Parker’s Indego® Exoskeleton for Clinical, Personal Use
Go back to FDA Clears Parker’s Indego® Exoskeleton for Clinical, Personal Use| Parker-Hannifin (NYSE: PH) | Delayed: 995.02 -16.18 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1011.20 | 52 Week High | $139.73 | |||
| Open | $1014.18 | 52 Week Low | $83.32 | |||
| Day High | $1015.99 | P/E | 147.41 | |||
| Day Low | $990.35 | EPS | $6.75 | |||
| Volume | 576,071 | |||||
